Drugs / Tissue engineered cartilage graft
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01605201 | Aug 2012 → Aug 2018 | articular cartilage disorder | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tissue engineered cartilage graft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01605201 ↗ |
| Modality | Cell therapy | “engineered autologous nasal chondrocyte-based cartilage grafts” PMID 27789021 ↗ Oct 2016 |